NCT07382063

Brief Summary

The traditional intra-fascial interscalene brachial plexus block (ISB) is already one of the routine anesthesia methods for pediatric upper limb surgeries in clinical practice. This study aims to clarify the effect of the extra-fascial interscalene brachial plexus block on the diaphragm function of school-age children, as well as its analgesic effect, and to compare it with the traditional intra-fascial ISB. It intends to explore a more effective and safer ISB method for children. With the aim of optimizing techniques and accurately evaluating, to balance the benefits of analgesia and safety, and thereby promoting the development of precise pediatric anesthesia.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Feb 2026Nov 2026

First Submitted

Initial submission to the registry

January 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 2, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

January 26, 2026

Last Update Submit

January 31, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • To evaluate the rate of diaphragmatic paralysis using ultrasound.

    From enrollment to the end of treatment at 2-3 days

Study Arms (2)

intra-fascial interscalene brachial plexus block (ISB)

PLACEBO COMPARATOR
Procedure: intra-fascial interscalene brachial plexus block (ISB)

extra-fascial interscalene brachial plexus block (ISB)

EXPERIMENTAL
Procedure: extra-fascial interscalene brachial plexus block (ISB)

Interventions

Perform an intra-fascial interscalene brachial plexus block by penetrating the brachial plexus fascia and injecting 0.5 ml/kg of 0.2% ropivacaine.

intra-fascial interscalene brachial plexus block (ISB)

Perform an extra-fascial interscalene brachial plexus block, positioning the needle tip 2-4 mm lateral to the brachial plexus sheath, at a level equidistant between the C5 and C6 roots, measured using the on-screen caliper tool. Inject 0.5 ml/kg of 0.2% ropivacaine for nerve blockade.

extra-fascial interscalene brachial plexus block (ISB)

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age range: School-aged children (6-12 years old).
  • Type of surgery: Upper limb surgery.
  • ASA classification: Grades I-II.

You may not qualify if:

  • Infection, anatomical deformity, or tumor at the puncture site.
  • Coagulation disorders (INR \> 1.4, platelet count \< 100 × 10⁹/L).
  • History of allergy to local anesthetics (ropivacaine).
  • Severe cardiopulmonary or neurological diseases (e.g., epilepsy, myopathy).
  • Pre-existing ipsilateral phrenic nerve paralysis or Horner syndrome.
  • Preoperative long-term use of analgesics (which may affect efficacy assessment).
  • Parent or child refusal to participate in the study.
  • Emergency surgery or inability to cooperate with assessments (e.g., severe developmental delay).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Sixth People's Hospital

Shanghai, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
anesthesiologist

Study Record Dates

First Submitted

January 26, 2026

First Posted

February 2, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Locations